Our industry must guard against the weaponization of supply chain resilience in healthcare purchasing. The post Health Systems’ Escalating Demands for Supply Chain Resilience Have Become Counterproductive appeared first on MedCity News.
Exact Sciences is paying $75 million up front for U.S. rights to a colorectal cancer blood test developed by rival Freenome. If approved, Freenome’s liquid biopsy will compete with a blood test from Guardant Health. The post Exact Sciences Teams Up With Freenome to Take on Guardant Health in Colorectal Cancer Screening appeared first on…
The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s acquisition of the home health provider, which includes the divestiture of 164 home health and hospice locations. The post DOJ: UHG, Amedisys Must Divest 164 Locations for Acquisition to Proceed appeared first on MedCity News.
The technology and expertise needed to solve this problem already exist — we just need the will to implement solutions that toss out the status quo and put children’s health first. The post Pediatricians Subsidize the Vaccinations That Keep Kids Healthy and Prevent Pandemics. They Shouldn’t Have To appeared first on MedCity News.
Cancer rates are climbing among younger Americans, and healthcare leaders are calling for earlier screenings, more convenient testing options and expanded health plan coverage to help catch cases before they’re fatal. From at-home tests to multi-cancer detection tools, stakeholders across the industry are working to boost access to early detection. The post Cancer Is on…
If we gut school-based care, we’re not only closing doors, we’re also deepening the racial and economic inequities that already shape our mental health system. We can’t claim to care about equity in healthcare if we’re willing to strip care from the very places that reach the kids who need it most. The post The…
The current system is failing vulnerable patients – those it was designed to help. While well-intentioned, the savings these programs promise rarely trickle down to patients. The post The Dysfunctional Drug Discount System’s Serious Implications on Patient Health appeared first on MedCity News.
The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition. The post BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes appeared first on MedCity News.
Translucent AI raised $7 million in seed funding to help healthcare providers better manage mounting financial pressures. Its AI-powered platform is designed to give hospital leaders instant, plain-language answers to complex financial questions. The post Meet the Startup That’s like ChatGPT for Provider Finances appeared first on MedCity News.
Through a new tool, Blue Shield of California members can now be notified when a clinician begins an e-prescription and view lower-cost alternatives. The post Blue Shield of California Launches New Digital Tool for Medication Transparency appeared first on MedCity News.